Table 4.
Summary of thermal simulation on Model II
| Metric | Inactive γ=121° No vaginal cooling |
Inactive γ=111° No vaginal cooling |
Inactive γ=101° No vaginal cooling |
Inactive γ=111° 35°C vaginal cooling |
Inactive γ=101° 35°C vaginal cooling |
Inactive γ=111° 25°C vaginal cooling |
Inactive γ=101° 25°C vaginal cooling |
|---|---|---|---|---|---|---|---|
| Inactive β | 59° | 69° | 79° | 69° | 79° | 69° | 79° |
| Urethral sparing | 1.3 mm | 1.3 mm | 1.3 mm | 1.4 mm | 1.4 mm | 1.4 mm | 1.4 mm |
| Penetration | 11.2 mm | 11.1 mm | 11.1 mm | 10.9 mm | 10.8 mm | 10.4 mm | 10.1 mm |
| deptha | |||||||
| Heated lengthb | 12.5 mm | 12.5 mm | 12.5 mm | 12.4 mm | 12.3 mm | 11.9 mm | 11.8 mm |
| Heated volume | 1.674 cm3 | 1.655 cm3 | 1.632 cm3 | 1.506 cm3 | 1.432 cm3 | 1.165 cm3 | 1.054 cm3 |
| (>60 EM43°C) | (−9.0%)c | (−12.3%)c | (−29.6%)c | (−35.4%)c | |||
| Coagulated | 0.940 cm3 | 0.928 cm3 | 0.914 cm3 | 0.836 cm3 | 0.790 cm3 | 0.603 cm3 | 0.531 cm3 |
| volume | (−10.0%)c | (−13.6%)c | (−35.0%)c | (−41.9%)c | |||
| (>240 EM43°C) | |||||||
| Max T | 57.3°C | 57.3°C | 57.3°C | 57.0°C | 56.9°C | 56.0°C | 55.7°C |
| Max Vagina T | 46.8°C | 47.9°C | 48.8°C | 45.7°C | 46.2°C | 41.5°C | 41.8°C |
| Max Vagina | 14.3 EM43°C | 29.0 EM43°C | 51.2 EM43°C | 6.8 EM43°C | 9.4 EM43°C | 0.09 EM43°C | 0.14 EM43°C |
| Dose | |||||||
| Max Bone T | 44.8°C | 44.5°C | 44.1°C | 44.5°C | 44.1°C | 44.4°C | 44.0°C |
| Max Bone Dose | 3.9 EM43°C | 3.2 EM43°C | 2.3 EM43°C | 3.1 EM43°C | 2.2 EM43°C | 2.9 EM43°C | 2.1 EM43°C |
| Coverage angles (>60 EM43°C) |
71.7° | 71.7° | 71.4° | 70.0° | 69.3° | 64.2° | 62.6° |
indicates the maximum penetration (>60 EM43°C) in radial direction
indicates the maximum length of heated zone (>60 EM43°C) along the applicator
denotes the heated volume reduction compared to the same applicator configurations without vaginal cooling